In brief: C3, SSH, Axon
Wednesday, 30 November, 2005
Clinical Cell Culture's (ASX:CCE) co-founder Prof Fiona Wood will step down from the company's board on December 31. She will remain as a consultant, an R&D partner through her research vehicle the McComb Foundation, and a substantial shareholder.
Shareholders at SSH Medical's (ASX:SSH) AGM yesterday approved a resolution to change the company's name to BioLayer Corporation, the unlisted Brisbane-based materials sciences company it acquired earlier this month.
Axon Instruments founder and former CEO Dr Alan Finkel has been appointed to the ATSE Clunies Ross board of governors. Finkel is the first winner of an ATSE Clunies Ross award to join the board.
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
